Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Pradines, Bruno ^a,b   Bertaux, Lionel ^a,b   Pomares, Christelle ^c,d   Delaunay, Pascal ^c,d   Marty, Pierre ^c,d  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

^b Centre National de Reference du Paludisme   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; DEETHYLAMODIAQUINE; DIHYDROARTEMISININ; DOXYCYCLINE; MEFLOQUINE; PIPERAQUINE; PYRIMETHAMINE; PYRONARIDINE; QUININE; QUININE DERIVATIVE; ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; PROTOZOAL PROTEIN;

ADULT; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG CLEARANCE; FEMALE; FEVER; GENETIC POLYMORPHISM; HUMAN; IC 50; IN VITRO STUDY; MALARIA; MICROSATELLITE MARKER; THAILAND; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; GENETICS; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; MIDDLE AGED; PARASITOLOGY; PLASMODIUM FALCIPARUM; SOUTHEAST ASIA; TRAVEL; TREATMENT OUTCOME;

ANTIMALARIALS; ARTEMISININS; ASIA, SOUTHEASTERN; DOXYCYCLINE; DRUG RESISTANCE; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MIDDLE AGED; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; QUININE; TRAVEL; TREATMENT OUTCOME;

EID: 80052869010     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-268     Document Type: Article

References (18)

1. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwrong M, Chotivanish K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
2. Resistance of Plasmodium falciparum field isolates to in vitro artemether and point mutations of the Serca-type PfATPase6. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O, Lancet 2005 366 1960 1963 10.1016/S0140-6736(05)67787-2 16325698 (Pubitemid 41713986)
3. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
4. Artemisinin-resistant malaria in Asia. Noedl H, Socheat D, Satimai W, N Eng J Med 2009 361 540 541 10.1056/NEJMc0900231
5. A multi-normal distribution model suitable for the distribution of Plasmodium falciparum in vitro chemosusceptibility to doxycycline. Briolant S, Baragatti M, Parola P, Simon F, Tall A, Sokhna C, Mamfoumbi MM, Koeck JL, Delmont J, Spiegel A, Castello J, Gardair JP, Trape JF, Kombila M, Minodier P, Fusai T, Rogier C, Pradines B, Antimicrob Agents Chemother 2009 53 688 695 10.1128/AAC.00546-08 19047651
6. La résistance aux antipaludiques. Pradines B, Dormoi J, Briolant S, Bogreau H, Rogier C, Rev Fr Lab 2010 422 51 62
7. Management and prevention of imported Plasmodium falciparum malaria: Recommendations for clinical practice 2007 (revision 2007 of the 1999 consensus conference). Med Mal Infect 2008 38 68 117 18646361
8. Methods for surveillance of antimalarial drug efficacy. World Health Organization, http://apps.who.int/malaria/docs/drugresistance/Protocol2009.pdf
9. Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Bogreau H, Renaud F, Bouchiba H, Durand P, Assi SB, Henry MC, Garnotel E, Pradines B, Fusai T, Wade B, Adehossi E, Parola P, Kamil MA, Puijalon O, Rogier C, Am J Trop Med Hyg 2006 74 953 959 16760503 (Pubitemid 351627399)
10. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Henry M, Diallo I, Bordes J, Ka S, Pradines B, Diatta B, M'Baye PS, Sane M, Thiam M, Gueye PM, Wade B, Touze JE, Debonne JM, Rogier C, Fusai T, Am J Trop Med Hyg 2006 75 146 151 16837722 (Pubitemid 351627584)
11. New pfATP6 mutations found in Plasmodium falciparum isolates from Vietnam. Bertaux L, Quang LH, Sinou V, Xuan Thanh N, Parzy D, Antimicrob Agents Chemother 2009 53 4570 4571 10.1128/AAC.00684-09 19687249
12. + exchanger 1 transporter is involved in reduced susceptibility to quinine. Henry M, Briolant S, Zettor A, Pelleau S, Baragatti M, Baret E, Mosnier J, Amalvict R, Fusai T, Rogier C, Pradines B, Antimicrob Agents Chemother 2009 53 1926 1930 10.1128/AAC.01243-08 19273668
13. Artesunate misuse and Plasmodium falciparum malaria in traveller returning from Africa. Shahinas D, Lau R, Khairnar K, Handock D, Pillai DR, Emerg Infect Dis 2010 16 1608 1610 20875291
14. Quinine-resistant malaria in traveler returning from Senegal, 2007. Pradines B, Pistone T, Ezzedine K, Briolant S, Bertaux L, Receveur MC, Parzy D, Millet P, Rogier C, Malvy D, Emerg Infect Dis 2010 16 546 548 20202443
15. Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Dahl E, Rosenthal P, Antimicrob Agents Chemother 2007 51 3485 3490 10.1128/AAC.00527-07 17698630 (Pubitemid 47519333)
16. Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates. Pradines B, Spiegel A, Rogier C, Tall A, Mosnier J, Fusai T, Trape JF, Parzy D, Am J Trop Med Hyg 2000 62 82 85 10761729 (Pubitemid 30180355)
17. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Pradines B, Rogier C, Fusai T, Mosnier J, Daries W, Baret E, Parzy D, Antimicrob Agent Chemother 2001 45 1746 1750 10.1128/AAC.45.6.1746- 1750.2001 (Pubitemid 32466344)
18. Quinine-resistant malaria in traveler returning from French Guiana, 2010. Bertaux L, Kraemer P, Taudon N, Trignol A, Martelloni M, Saidi R, Parzy D, Pradines B, Simon F, Emerg Infect Dis 2011 17 943 945 21529424